Bevacizumab in combination with oxaliplatin and either fluorouracil plus folinic acid or capecitabine for the treatment of metastatic colorectal cancer

  • Technology appraisal guidance
  • TA212
  • Published: 

Do no do examples

Title Year published Impact Level
No results could be found